The latter further directly suppresses the expression of C-Myc, a key oncogenic transcription factor inducing the pathogenesis of tumours [15,16], participating in the inhibition of CCDC19-mediated cell cycle transition and the growth of NSCLC. The gene discussed is MYC; the disease is non-small cell lung carcinoma.